2006•Journal of Health Care and Medicine in Chinese PLARequires access

A comparative study of buflomedil and fufang-danshen in treating cerebral infarction

Xia Xiang-nan

Open publisher page 0 citations

Abstract

Objective To study the therapeutic effects of buflomedil—a new vasomotor of multiple pharmacological function in treating cerebral infarction. Methods Thirty-seven patients with cerebral infarction treated with buflomedil through intravenous injection for 14 days, and the control group was treated with fufang-danshen. The changes in total score of neurological functional damage were observed and the hemorheology was surveyed in the patients before and after treatment. Results The total clinical effective rate and remarkable effective rate in patients treated with buflomedil were 89.2%,72.9%,respectively,greater than those of control ( 74.3%,54.3%,respectively )(P0.05). Conclusions The result suggest that buflomedil is a safe and effective drug in treating patients with cerebral infarction.

About this research paper

What this paper is about

Objective To study the therapeutic effects of buflomedil—a new vasomotor of multiple pharmacological function in treating cerebral infarction. Methods Thirty-seven patients with cerebral infarction treated with buflomedil through intravenous injection for 14 days, and the control group was treated with fufang-danshen. The changes in total score of neurological functional damage were observed and the hemorheology was surveyed in the patients before and after treatment. Results The total clinical effective rate and remarkable effective rate in patients treated with buflomedil were 89.2%,72.9%,respectively,greater than those of control ( 74.3%,54.3%,respectively )(P0.05). Conclusions The result suggest that buflomedil is a safe and effective drug in treating patients with cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the therapeutic effects of buflomedil—a new vasomotor of multiple pharmacological function in treating cerebral infarction. Methods Thirty-seven patients with cerebral infarction treated with buflomedil through intravenous injection for 14 days, and the control group was treated with fufang-danshen. The changes in total score of neurological functional damage were observed and the hemorheology was surveyed in the patients before and after treatment. Results The total clinical effective rate and remarkable effective rate in patients treated with buflomedil were 89.2%,72.9%,respectively,greater than those of control ( 74.3%,54.3%,respectively )(P0.05). Conclusions The result suggest that buflomedil is a safe and effective drug in treating patients with cerebral infarction.

Key concepts: Medicine, Cerebral infarction, Hemorheology, Vasomotor, Anesthesia, Infarction, Therapeutic effect, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A comparative study of buflomedil and fufang-danshen in treating cerebral infarction — Research Paper | ScholarLens